Theratechnologies (TSE:TH) Sets New 1-Year High – Here’s Why

Shares of Theratechnologies Inc. (TSE:TH) hit a new 52-week high during mid-day trading on Friday . The company traded as high as C$3.15 and last traded at C$2.69, with a volume of 1488590 shares changing hands. The stock had previously closed at C$1.85.

Wall Street Analyst Weigh In

Separately, Research Capitl raised shares of Theratechnologies to a “strong-buy” rating in a report on Friday, February 14th.

Theratechnologies Stock Up 48.6 %

The company has a 50 day moving average of C$2.30 and a 200-day moving average of C$2.14. The company has a debt-to-equity ratio of -293.92, a current ratio of 1.08 and a quick ratio of 0.64. The company has a market cap of C$87.74 million, a P/E ratio of -31.13, a price-to-earnings-growth ratio of -8.50 and a beta of 1.73.

Theratechnologies Company Profile

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.